Idraparinux
- Generic Name
- Idraparinux
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C38H64O49S7
- CAS Number
- 162610-17-5
- Unique Ingredient Identifier
- 6ADD3H8MFZ
- Background
Idraparinux, a synthetic pentasaccharide is an antithrombin-dependent inhibitor of activated factor X. It was developed for the treatment and prevention of thromboembolic events. However, clinical trials have revealed that idraparinux had lead to bleeding. As a result, Sanofi stopped the development of the drug.
- Indication
Investigated for use/treatment in thrombosis, venous thromboembolism, strokes, heart disease, and atrial fibrillation.
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath